Theresa Agnew commences her role as CEO of BioGaia
BioGaia announces that Theresa Agnew begins her role today, 25 September 2023, as the Chief Executive Officer of BioGaia....
Read moreIntroducing BioGaia Prodentis KIDS in Sweden
BioGaia introduces Prodentis for kids, an apple-flavored lozenge with probiotics and xylitol for oral health, to complement the daily...
Read moreBioGaia and University of Gothenburg reach an important milestone towards next-generation probiotics
In a paper published in the journal Nature, a team of researchers from the University of Gothenburg and MetaboGen, a...
Read moreBioGaia appoints Theresa Agnew as new CEO
Today BioGaia´s board of directors has appointed Theresa P. Agnew as the new chief executive officer....
Read moreBioGaia AB: Interim Management Statement January – June 2023
SECOND QUARTER 2023 Figures in parentheses refer to the corresponding period last year, unless otherwise specified. · Net sales amounted to...
Read moreInvitation to media and analyst briefing for BioGaia Q2 2023 report
BioGaia's (NASDAQ: BIOG) financial report for the second quarter of 2023 will be published at approximately 8:00 AM...
Read moreBioGaia’s probiotic Protectis increases SARS-CoV-2 antibody response in adults
A randomised, triple-blinded, placebo-controlled study with BioGaia’s probiotic Protectis was shown to increase SARS-CoV-2 antibody...
Read moreBioGaia earns Gold Medal from EcoVadis for Sustainability Performance
BioGaia has been awarded a gold medal recognizing its sustainability achievements by EcoVadis, one of the world's most trusted...
Read moreAnnual General Meeting of BioGaia
The Annual General Meeting of BioGaia AB (publ) on 5 May 2023 voted, among other things, to approve the following...
Read more